ENZYMAX DUALRELEASE
Developing nutraceuticals capable of replacing pharmaceuticals
We also provide solutions in situations where suitable products are lacking
The problem
Digestive Enzymes
Digestive Enzymes are responsible for the chemical reactions necessary to break down food.
The stomach digests food (e.g. proteins) and pushes the digested food (chyme) into the intestine.
The intestine digests mainly fats (lipase) and absorbs the nutrients.
The more digested the chyme is, the smoother the intestinal functions flow.
Innovative technology CAP IN CAP
The external capsule
Stomach release
The internal capsule
Intestinal release
The main digestive benefit:
Digestive enzymatic complex, the optimal solution due to a number of breakthroughs:
DualRelease is different
Why Enzymax DualRelease works differently?:
A highly important and unique feature of Enzymax DualRelease is that it advances fats digestion to the stomach.
With Enzymax DualRelease the digestion of carbohydrates, proteins and fats begins in the stomach, helping the intestine to focus on nutrient absorption and microbiota rebalancing.
Testing the hydrolitic effect of Enzymax against pancreatin 10,000:
Enzymax constitutes an alternative of pancreatic enzyme replacement therapy (PERT) for Cystic Fibrosis patients.
A study has been carried out in collaboration with the Cuban Ministry of Health and the Association of Cuban Cystic Fibrosis in patients under long term with pancreatin 25,000 treatment.
In the comparison of Enzymax with pancreatin 25,000, there was a statistically significant reduction in the number of pills intake by 3-fold and > 80% reduction of gastrointestinal symptoms as:
Enzymax is effective in the treatment of moderate to severe dyspepsia symptoms.
A study was conducted on Enzymax in 105 patients with moderate-severe dyspepsia. The study focused on symptomatology reduction and administration optimization. The Dyspepsia Index was used to evaluate symptomatology.
The results with the administration of 1 capsule 20 days, or 2 capsules in 10 days, showed that:
DICODI (Digestive Complications in Diabetes) epidemiology study ongoing in collaboration with Aalborg University (Denmark), Uppsala University and Karolinska Institutet
Ingredients
Enzymax Dual Release is indicated for people suffering from indigestion or dyspepsia, symptoms such as postprandial discomfort, epigastric fullness or flatulence. Also for irritable bowel syndrome (IBS) and gastrointesital diabetes-associated symptoms.
Enzymax DualRelease is a combination of microbial digestive enzymes targeting both stomach and intestinal digestion, with a fast and innovative technology. Thanks to these features, Enzymax DualRelease is able to offer a complete aid throuhgout the digestive tract, begining from the stomach.
According to the available technical information, digestive enzymes are well-tolerated with no reported side effects at the recommended doses. In the case of pregnancy, breastfeeding, patients undergoing surgery or under treatment with anticoagulants or antiinflammatory drugs, please consult your doctor before using this product.
The advisable dose is to take 1-2 capsules at the start of the main meal or as determined by a doctor.
Nutraceutical Research and Development Company
We are part of AORA Health, a nutraceutical research and development company.
We create innovative, scientifically proven solutions with specific benefits designed to complement or replace pharmaceuticals.
Our mission is to improve people’s well-being through nutraceutical products with proven benefits and the backing of science.
